ESMO 2021 Roundup

Managing patients with EGFR exon 20 ins in NSCLC and EGFR TKI toxicity

New MM patients with high levels of circulating tumour cells distinguished by increased bone marrow plasma cell proliferation

Exceptional response to oral metronomic chemotherapy in a rare case of sinonasal mucosal melanoma

PARP inhibitors in prostate cancer: Case based testing and clinical decisions

Anti-cancer drug price regulation in India: Financial implications and annual savings to patients

Disparities in myeloma: Closing the gap

Long-term outcomes and complications in cancer patients who have recovered from COVID-19

Erdafitinib (ERDA) or ERDA plus cetrelimab for patients with metastatic or locally advanced urothelial carcinoma (mUC) and FGFRa

OncoAlert and ecancer - ESMO 2021 preview

Safety and efficacy of isatuximab plus bortezomib, lenalidomide, and dexamethasone combined therapy for NDMM

Multidisciplinary management of ovarian germ cell tumours - a single institutional study from India